NCT04474613 is a NA clinical trial of Liquid biopsy in Non Small Cell Lung Cancer, sponsored by Case Comprehensive Cancer Center.

Who is sponsoring NCT04474613?

NCT04474613 is sponsored by Case Comprehensive Cancer Center.

What drugs are being tested in NCT04474613?

Interventions in NCT04474613: Liquid biopsy.

What condition does NCT04474613 study?

NCT04474613 studies Non Small Cell Lung Cancer.

Is NCT04474613 still recruiting?

NCT04474613 is currently terminated. Last updated 5 February 2025.

Last reviewed 2025-02-05 · How we verify

NCT04474613

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites

Terminated NA Last updated 5 February 2025

What this trial tests

NA trial testing Liquid biopsy in Non Small Cell Lung Cancer in 26 participants. Terminated before completion.

Timeline

27 August 2020

Primary endpoint
10 February 2022

10 February 2022

Quick facts

Lead sponsor	Case Comprehensive Cancer Center
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	26
Start date	27 August 2020
Primary completion	10 February 2022
Estimated completion	10 February 2022
Sites	1 location across United States

Drugs / interventions tested

Liquid biopsy — full drug profile →

Conditions studied

Non Small Cell Lung Cancer — all drugs for Non Small Cell Lung Cancer →

Sponsor

Case Comprehensive Cancer Center — full company profile →

Who can join

18 and older, any sex, with Non Small Cell Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if liquid biopsies will reduce time to begin treatment in participants with non-small cell lung cancer (NSCLC). A liquid biopsy is a test done on a sample of blood to look for cancer cells.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer.
Bożyk A, Nicoś M. · · 2022 · cited 6× · PMID 36295075 · DOI 10.3390/life12101640

Verify or expand the search:

Other trials of Liquid biopsy

Trials testing the same drug.

NCT06605443 — Precision Medicine for L/GCMN and Melanoma 2 · recruiting
NCT06283576 — Pancreatic Cancer Initial Detection Via Liquid Biopsy · enrolling by invitation
NCT06592716 — Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples? · active not recruiting
NCT07418125 — Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA · NA · recruiting
NCT06605417 — Understanding the Transition from Normal Melanocytes to Nevus to Melanoma · recruiting

Other recruiting trials for Non Small Cell Lung Cancer

Currently open trials in the same condition.

NCT06951646 — ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immuno · Phase 2 · recruiting
NCT07503808 — A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · Phase 1 · recruiting
NCT07269782 — A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCL · Phase 2 · recruiting
NCT07306624 — Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer · Phase 2 · recruiting
NCT07323732 — A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas · Phase 2 · recruiting

Other Case Comprehensive Cancer Center trials

Trials by the same sponsor.

NCT06811454 — Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) · NA · not yet recruiting
NCT07167056 — Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer · NA · recruiting
NCT07084779 — Investigation of Impact of AI on Prostate Cancer Workflow · NA · recruiting
NCT06904482 — Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · Phase 2 · recruiting
NCT07044362 — Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04474613 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Case Comprehensive Cancer Center
Last refreshed: 5 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04474613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing